Todd Harris sold $1.5M of TYRA
President and CEO at Tyra Biosciences, Inc.. 58,726 shares at an average of $25.77, traded Oct 15, 2024, filed Oct 17, 2024.
Score components
- +25RoleCEO
- +25Trade size$1.5M at market
- 0Share of holdings soldSold 4.0% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -40.8%, 3m -37.8%, 6m -65.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-115432, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | SOpen-market sale Common Stock10b5-1 | -10,035 | $24.31 | $244k | 1,467,338 | Oct 17, 2024 |
| Oct 16, 2024 | SOpen-market sale Common Stock10b5-1 | -4,900 | $25.22 | $124k | 1,462,438 | Oct 17, 2024 |
| Oct 16, 2024 | SOpen-market sale Common Stock10b5-1 | -24,475 | $26.23 | $642k | 1,437,963 | Oct 17, 2024 |
| Oct 16, 2024 | SOpen-market sale Common Stock10b5-1 | -3,922 | $26.98 | $106k | 1,434,041 | Oct 17, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -15,194 | $25.84 | $393k | 1,418,847 | Oct 17, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -200 | $26.37 | $5,274 | 1,418,647 | Oct 17, 2024 |
Related signals
Other insiders at Tyra Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | TYRAbuy Tyra Biosciences, Inc. | Rehan Verjee director | $20k 972 shares | - | |
| 35Weak | TYRAsell Tyra Biosciences, Inc. | Gilla Kaplan director | $94k 9,578 shares | -25% | |
| 53Moderate | TYRAsell Tyra Biosciences, Inc. | Gilla Kaplan director | $535k 51,814 shares | -58% | |
| 48Moderate | TYRAbuy Tyra Biosciences, Inc. | Ra Capital Management, L.p. director, owner | $1.7M 163,287 shares | +2% | |
| 48Moderate | TYRAbuy Tyra Biosciences, Inc. | Ra Capital Management, L.p. director, owner | $1.9M 186,850 shares | +2% | |
| 46Moderate | TYRAbuy Tyra Biosciences, Inc. | Ra Capital Management, L.p. director, owner | $12M 1,211,198 shares | +14% | |
| 23Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $74k 5,401 shares | -0% | |
| 24Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $78k 4,825 shares | -0% | |
| 31Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $410k 25,041 shares | -1% | |
| 24Weak | TYRAsell Tyra Biosciences, Inc. | Nina S Kjellson director | $89k 5,272 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.